A novel integrated biomarker index for the assessment of hematological responses in <scp>MPNs</scp> during treatment with hydroxyurea and interferon‐alpha2-Reference-Cited by-同舟云学术

A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon‐alpha2

Published:2022-10-17 Issue:4 Volume:12 Page:4218-4226
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Dam Marc J. B.¹,Pedersen Rasmus K.¹^ORCID,Knudsen Trine A.²^ORCID,Andersen Morten¹^ORCID,Ellervik Christina³⁴^ORCID,Larsen Morten Kranker²^ORCID,Kjær Lasse²^ORCID,Skov Vibe²^ORCID,Hasselbalch Hans C.²^ORCID,Ottesen Johnny T.¹^ORCID

Affiliation:

1. Centre for Mathematical Modeling ‐ Human Health and Disease (COMMAND), IMFUFA, Department of Science and Environment Roskilde University Roskilde Denmark

2. Department of Haematology Zealand University Hospital Roskilde Denmark

3. Department of Research, Production, Innovation, Region Zealand Sorø Denmark

4. Department of Pathology Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5285

Reference46 articles.

1. Myeloproliferative Neoplasms

2. Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

4. Myelofibrosis with myeloid metaplasia: The advanced phase of an untreated disseminated hematological cancer

5. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging, Inflammation, and Comorbidity in Cancers—A General In Silico Study Exemplified by Myeloproliferative Malignancies;Cancers;2023-09-29

2. JAK2 V617F allele burden in polycythemia vera: burden of proof;Blood;2023-04-20

3. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera;Expert Review of Hematology;2023-04-05